Concepedia

Andrea Kay

AK

Statistics

Publications

44

Citations

11.4K

H-Index

30

Active since

1991

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

King's College London

Scripps Health

University College London

Istituti di Ricovero e Cura a Carattere Scientifico

Andrea Kay is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1991–2024

44

Publications

44

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · The Lancet · 2008 · 3K citations

, , +11

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

, , +17

Phase 3 trial of everolimus for metastatic renal cell carcinoma

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · Cancer · 2010 · 1.1K citations

, , +17

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

, , +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

, , +11

1–5 of 44